성장인자 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2031년) - 제품, 등급, 용도, 최종 사용자 및 지역별
Growth Factors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
상품코드
:
1394153
리서치사
:
Fairfield Market Research
발행일
:
2023년 12월
페이지 정보
:
영문 391 Pages
샘플 요청 목록에 추가
세계 성장인자 시장 규모는 2024년 22억 달러에서 2031년 말 38억 달러로 크게 확대될 것으로 예상됩니다. 이러한 성장을 주도하는 데 있어 제조업체는 피부 재생, 상처 치유 및 치료 용도에 혁명을 일으키고 있는 매우 중요한 역할을 하고 있습니다.
성장인자는 피부 재생과 상처 치유의 초석으로 등장했습니다. 연구자들은 단일 성장인자 솔루션에 국한되지 않는 선구적인 제품 개발에 열정을 쏟고 있으며, 이는 시장에 큰 성장 기회를 열어주고 있습니다. 또한, 아시아태평양의 급격한 성장과 GMP(Good Manufacturing Practice) 등급 제품을 전문으로 하는 소수의 기업들은 성장인자 제조업체들에게 큰 잠재력을 제공합니다.
다양한 질병 치료에서 사이토카인과 성장인자의 치료 가능성은 시장 확대를 촉진할 것으로 예상됩니다. 자가 면역 질환과 암의 유병률 증가는 이러한 성장 궤도를 더욱 촉진할 것입니다.
업계를 선도하는 기업들은 신제품 승인, 출시, 공동연구, 계약 및 제휴에 전략적으로 집중하고 있습니다. 이러한 전략은 제품 포트폴리오를 강화하고 지역적 입지를 확대하는 것을 목표로 하고 있습니다. R&D 투자와 함께 M&A는 다양한 치료 및 과학 분야에서 성장인자을 활용하기 위한 주요 전략입니다.
그러나 성장인자 시장은 주로 높은 비용과 숙련된 전문가 부족으로 인한 어려움에 직면해 있습니다. 특정 성장인자의 비용은 실험실에서 채택하는 것을 방해하고 있습니다. 자격을 갖춘 전문가가 적고 필요한 장비와 액세서리에 대한 접근이 제한되어 시장 확장을 더욱 방해하고 있습니다.
이 보고서는 세계의 성장인자 시장에 대해 조사했으며, 시장 개요와 함께 제품별/등급별/용도별/최종 사용자별/지역별 동향, 시장 진출기업의 경쟁 동향 등의 정보를 제공합니다.
목차 제1장 주요 요약
제2장 시장 개요
시장 정의와 세분화
시장 역학
밸류체인 분석
Porter의 Five Forces 분석
COVID-19의 영향 분석
우크라이나와 러시아 분쟁의 영향
경제 개요
PESTLE 분석
제3장 세계의 성장인자 시장 전망, 2018년-2031년
세계의 성장인자 시장 전망, 제품별, 금액, 수량, 2018년-2031년
세계의 성장인자 시장 전망, 등급별, 금액, 수량, 2018년-2031년
세계의 성장인자 시장 전망, 용도별, 금액, 수량, 2018년-2031년
세계의 성장인자 시장 전망, 최종사용자별, 금액, 수량, 2018년-2031년
세계의 성장인자 시장 전망, 지역별, 금액, 수량, 2018년-2031년
제4장 북미의 성장인자 시장 전망, 2018년-2031년
제5장 유럽의 성장인자 시장 전망, 2018년-2031년
제6장 아시아태평양의 성장인자 시장 전망, 2018년-2031년
제7장 라틴아메리카의 성장인자 시장 전망, 2018년-2031년
제8장 중동 및 아프리카의 성장인자 시장 전망, 2018년-2031년
제9장 경쟁 구도
용도별/등급별 히트맵
제조업체 및 등급별 히트맵
기업의 시장 점유율 분석, 2023년
경쟁력 대시보드
기업 개요
Thermo Fisher Scientific Inc.
Lonza Group AG
Merck KGaA
General Electronics Company
F. Hoffmann-La Roche Ltd
Applied Biological Materials(abm), Inc
Abcam plc.
Cell Signaling Technology, Inc.
Sartorius CellGenix GmbH
Bio-Techne
Proteintech Group, Inc
Miltenyi Biotec
Creative Bioarray
Akron Biotech
Sino Biological Inc.
Repligen corporation
LEADGENE BIOMEDICAL, INC.
PeproTech In
제10장 부록
LSH
영문 목차
The global growth factors market is poised for substantial expansion, with a remarkable surge in revenue from US $2.2 billion in 2024 to an estimated US $3.8 billion by the end of 2031. Manufacturers are playing a pivotal role in propelling this growth, revolutionizing skin regeneration, wound healing, and therapeutic applications.
Manufacturers Spearhead Market Growth
Growth factors have emerged as a cornerstone for skin regeneration and wound healing. Researchers are diligently working on pioneering products that extend beyond single growth factor solutions, paving the way for significant opportunities in the market. Additionally, the rapid growth of the Asia Pacific region and a limited number of companies specializing in Good Manufacturing Practice (GMP)-grade products create vast prospects for growth factor manufacturers.
Cytokine and Growth Factors Therapy Expands
The therapeutic potential of cytokine and growth factors in treating a range of disorders is expected to bolster market expansion. The rising prevalence of autoimmune diseases and cancer further fuels this growth trajectory.
Key Players Drive Expansion
Leading industry players are strategically focusing on new product approvals, launches, collaborations, agreements, and partnerships. These tactics are aimed at strengthening product portfolios and expanding regional presence. Mergers and acquisitions, along with investments in research and development, are also key strategies to harness growth factors in various therapeutic and scientific domains.
Challenges Ahead
However, the growth factors market faces its share of challenges, primarily stemming from high costs and a shortage of skilled professionals. The cost of certain growth factors hampers their adoption in research laboratories. A dearth of qualified experts and limited access to necessary equipment and accessories further impede market expansion.
Country-wise Insights
Why the U.S. is Thriving
The United States is witnessing a burgeoning demand for growth factors, driven by government initiatives supporting research activities and the growing importance of growth factors and cytokines in stem cell biology.
China's Emergence
China has become a prominent market for growth factors, particularly in the wake of the COVID-19 pandemic. As larger Chinese companies focus on developing growth factor-based medicines to combat the virus, the market for these products is rapidly expanding throughout China and East Asia.
Germany's Appeal
Germany stands out as a lucrative market for growth factors in Europe due to rising healthcare spending and the presence of robust manufacturing facilities. Major companies are expanding their product offerings through strategic acquisitions, such as Sartorius AG's acquisition of CellGenix in 2021 to bolster its cell and gene therapy product line.
Competitive Landscape
Key players in the growth factors market, including Thermo Fisher Scientific, Lonza Group AG, Merck KGaA, and others, are actively pursuing strategies to enhance their global presence. These strategies encompass new product releases, business expansion, approvals, partnerships, agreements, collaborations, and diversified distribution channels, including online sales.
Key Companies Profiled:
Thermo Fisher Scientific
Lonza Group AG
Merck KGaA
General Electronics Company
F. Hoffmann-La Roche Ltd
Applied Biological Materials (abm), Inc
Abcam plc.
Cell Signaling Technology, Inc.
Meridian Bioscience Inc.
Sartorius CellGenix GmbH
Bio-Techne.
Proteintech Group, Inc.
Miltenyi Biotec
Creative Bioarray
Akron Biotech
Sino Biological Inc.
Repligen Corporation
LEADGENE BIOMEDICAL, INC.
PeproTech Inc.
Key Segments of the Growth Factors Industry Research:
By Product:
Transforming Growth Factors (TGF)
Activin
Bone Morphogenetic Proteins (BMPs)
TGF-beta Proteins
Epidermal Growth Factors (EGFs)
Platelet-Derived Growth Factors (PDGFs)
Fibroblast Growth Factors (FGFs)
Insulin-like Growth Factors (IGFs)
Vascular Endothelial Growth Factors (VEGFs)
Hepatocyte Growth Factors (HGFs)
Tumour Necrosis Factors (TNFs)
Interleukins
Others
By Grade:
By Application:
Oncology Research
Hematology Research
Wound Healing Research
Dermatology Research
Cardiovascular Disease & Diabetes
Cell therapy and Ex vivo manufacturing
Others
By End User:
Pharmaceutical and Biotechnology Companies
Research Centres & Academic Institutes
CMO and CDMO
By Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa
Table of Contents 1. Executive Summary
1.1. Global Growth Factors Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Growth Factors Market Outlook, 2018 - 2031
3.1. Global Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Transforming Growth Factors (TGF)
3.1.1.1.1. Activin
3.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
3.1.1.1.3. TGF-beta Proteins
3.1.1.2. Epidermal Growth Factors (EGFs)
3.1.1.3. Platelet-Derived Growth Factors (PDGFs)
3.1.1.4. Fibroblast Growth Factors (FGFs)
3.1.1.5. Insulin-like Growth Factors (IGFs)
3.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
3.1.1.7. Hepatocyte Growth Factors (HGFs)
3.1.1.8. Tumour Necrosis Factors (TNFs)
3.1.1.9. Interleukins
3.1.1.10. Others
3.2. Global Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. GMP Grade
3.2.1.2. NON-GMP Grade
3.3. Global Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Oncology Research
3.3.1.2. Hematology Research
3.3.1.3. Wound Healing Research
3.3.1.4. Dermatology Research
3.3.1.5. Cardiovascular Disease & Diabetes
3.3.1.6. Cell therapy and Ex vivo manufacturing
3.3.1.7. Others
3.4. Global Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. Pharmaceutical and Biotechnology Companies
3.4.1.2. Research Centres & Academic Institutes
3.4.1.3. CMO and CDMO
3.5. Global Growth Factors Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Growth Factors Market Outlook, 2018 - 2031
4.1. North America Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Transforming Growth Factors (TGF)
4.1.1.1.1. Activin
4.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
4.1.1.1.3. TGF-beta Proteins
4.1.1.2. Epidermal Growth Factors (EGFs)
4.1.1.3. Platelet-Derived Growth Factors (PDGFs)
4.1.1.4. Fibroblast Growth Factors (FGFs)
4.1.1.5. Insulin-like Growth Factors (IGFs)
4.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
4.1.1.7. Hepatocyte Growth Factors (HGFs)
4.1.1.8. Tumour Necrosis Factors (TNFs)
4.1.1.9. Interleukins
4.1.1.10. Others
4.2. North America Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. GMP Grade
4.2.1.2. NON-GMP Grade
4.3. North America Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Oncology Research
4.3.1.2. Hematology Research
4.3.1.3. Wound Healing Research
4.3.1.4. Dermatology Research
4.3.1.5. Cardiovascular Disease & Diabetes
4.3.1.6. Cell therapy and Ex vivo manufacturing
4.3.1.7. Others
4.4. North America Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. Pharmaceutical and Biotechnology Companies
4.4.1.2. Research Centres & Academic Institutes
4.4.1.3. CMO and CDMO
4.5. North America Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. U.S. Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.5.1.2. U.S. Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.5.1.3. U.S. Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.5.1.4. U.S. Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.5.1.5. Canada Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.5.1.6. Canada Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.5.1.7. Canada Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.5.1.8. Canada Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Growth Factors Market Outlook, 2018 - 2031
5.1. Europe Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Transforming Growth Factors (TGF)
5.1.1.1.1. Activin
5.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
5.1.1.1.3. TGF-beta Proteins
5.1.1.2. Epidermal Growth Factors (EGFs)
5.1.1.3. Platelet-Derived Growth Factors (PDGFs)
5.1.1.4. Fibroblast Growth Factors (FGFs)
5.1.1.5. Insulin-like Growth Factors (IGFs)
5.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
5.1.1.7. Hepatocyte Growth Factors (HGFs)
5.1.1.8. Tumour Necrosis Factors (TNFs)
5.1.1.9. Interleukins
5.1.1.10. Others
5.2. Europe Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. GMP Grade
5.2.1.2. NON-GMP Grade
5.3. Europe Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Oncology Research
5.3.1.2. Hematology Research
5.3.1.3. Wound Healing Research
5.3.1.4. Dermatology Research
5.3.1.5. Cardiovascular Disease & Diabetes
5.3.1.6. Cell therapy and Ex vivo manufacturing
5.3.1.7. Others
5.4. Europe Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Pharmaceutical and Biotechnology Companies
5.4.1.2. Research Centres & Academic Institutes
5.4.1.3. CMO and CDMO
5.5. Europe Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. Germany Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.2. Germany Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.3. Germany Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.4. Germany Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.5. U.K. Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.6. U.K. Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.7. U.K. Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.8. U.K. Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.9. France Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.10. France Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.11. France Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.12. France Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.13. Italy Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.14. Italy Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.15. Italy Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.16. Italy Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.17. Turkey Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.18. Turkey Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.19. Turkey Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.20. Turkey Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.21. Russia Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.22. Russia Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.23. Russia Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.24. Russia Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.25. Rest of Europe Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.26. Rest of Europe Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.27. Rest of Europe Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.28. Rest of Europe Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Growth Factors Market Outlook, 2018 - 2031
6.1. Asia Pacific Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Transforming Growth Factors (TGF)
6.1.1.1.1. Activin
6.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
6.1.1.1.3. TGF-beta Proteins
6.1.1.2. Epidermal Growth Factors (EGFs)
6.1.1.3. Platelet-Derived Growth Factors (PDGFs)
6.1.1.4. Fibroblast Growth Factors (FGFs)
6.1.1.5. Insulin-like Growth Factors (IGFs)
6.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
6.1.1.7. Hepatocyte Growth Factors (HGFs)
6.1.1.8. Tumour Necrosis Factors (TNFs)
6.1.1.9. Interleukins
6.1.1.10. Others
6.2. Asia Pacific Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. GMP Grade
6.2.1.2. NON-GMP Grade
6.3. Asia Pacific Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Oncology Research
6.3.1.2. Hematology Research
6.3.1.3. Wound Healing Research
6.3.1.4. Dermatology Research
6.3.1.5. Cardiovascular Disease & Diabetes
6.3.1.6. Cell therapy and Ex vivo manufacturing
6.3.1.7. Others
6.4. Asia Pacific Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Pharmaceutical and Biotechnology Companies
6.4.1.2. Research Centres & Academic Institutes
6.4.1.3. CMO and CDMO
6.5. Asia Pacific Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. China Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.2. China Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.3. China Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.4. China Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.5. Japan Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.6. Japan Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.7. Japan Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.8. Japan Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.9. South Korea Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.10. South Korea Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.11. South Korea Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.12. South Korea Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.13. India Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.14. India Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.15. India Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.16. India Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.17. Southeast Asia Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.18. Southeast Asia Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.19. Southeast Asia Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.20. Southeast Asia Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.21. Rest of Asia Pacific Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.22. Rest of Asia Pacific Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.23. Rest of Asia Pacific Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.24. Rest of Asia Pacific Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Growth Factors Market Outlook, 2018 - 2031
7.1. Latin America Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Transforming Growth Factors (TGF)
7.1.1.1.1. Activin
7.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
7.1.1.1.3. TGF-beta Proteins
7.1.1.2. Epidermal Growth Factors (EGFs)
7.1.1.3. Platelet-Derived Growth Factors (PDGFs)
7.1.1.4. Fibroblast Growth Factors (FGFs)
7.1.1.5. Insulin-like Growth Factors (IGFs)
7.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
7.1.1.7. Hepatocyte Growth Factors (HGFs)
7.1.1.8. Tumour Necrosis Factors (TNFs)
7.1.1.9. Interleukins
7.1.1.10. Others
7.2. Latin America Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.2.1.1. GMP Grade
7.2.1.2. NON-GMP Grade
7.3. Latin America Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Oncology Research
7.3.1.2. Hematology Research
7.3.1.3. Wound Healing Research
7.3.1.4. Dermatology Research
7.3.1.5. Cardiovascular Disease & Diabetes
7.3.1.6. Cell therapy and Ex vivo manufacturing
7.3.1.7. Others
7.4. Latin America Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Pharmaceutical and Biotechnology Companies
7.4.1.2. Research Centres & Academic Institutes
7.4.1.3. CMO and CDMO
7.5. Latin America Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Brazil Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.2. Brazil Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.3. Brazil Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.4. Brazil Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.5. Mexico Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.6. Mexico Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.7. Mexico Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.8. Mexico Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.9. Argentina Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.10. Argentina Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.11. Argentina Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.12. Argentina Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.13. Rest of Latin America Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.14. Rest of Latin America Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.15. Rest of Latin America Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.16. Rest of Latin America Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Growth Factors Market Outlook, 2018 - 2031
8.1. Middle East & Africa Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Transforming Growth Factors (TGF)
8.1.1.1.1. Activin
8.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
8.1.1.1.3. TGF-beta Proteins
8.1.1.2. Epidermal Growth Factors (EGFs)
8.1.1.3. Platelet-Derived Growth Factors (PDGFs)
8.1.1.4. Fibroblast Growth Factors (FGFs)
8.1.1.5. Insulin-like Growth Factors (IGFs)
8.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
8.1.1.7. Hepatocyte Growth Factors (HGFs)
8.1.1.8. Tumour Necrosis Factors (TNFs)
8.1.1.9. Interleukins
8.1.1.10. Others
8.2. Middle East & Africa Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. GMP Grade
8.2.1.2. NON-GMP Grade
8.3. Middle East & Africa Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Oncology Research
8.3.1.2. Hematology Research
8.3.1.3. Wound Healing Research
8.3.1.4. Dermatology Research
8.3.1.5. Cardiovascular Disease & Diabetes
8.3.1.6. Cell therapy and Ex vivo manufacturing
8.3.1.7. Others
8.4. Middle East & Africa Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Pharmaceutical and Biotechnology Companies
8.4.1.2. Research Centres & Academic Institutes
8.4.1.3. CMO and CDMO
8.5. Middle East & Africa Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. GCC Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.2. GCC Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.3. GCC Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.4. GCC Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.5. South Africa Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.6. South Africa Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.7. South Africa Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.8. South Africa Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.9. Egypt Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.10. Egypt Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.11. Egypt Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.12. Egypt Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.13. Nigeria Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.14. Nigeria Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.15. Nigeria Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.16. Nigeria Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.17. Rest of Middle East & Africa Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.18. Rest of Middle East & Africa Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.19. Rest of Middle East & Africa Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.20. Rest of Middle East & Africa Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. by Application vs by Grade Heatmap
9.2. Manufacturer vs by Grade Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Thermo Fisher Scientific Inc.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Lonza Group AG
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Merck KGaA
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. General Electronics Company
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. F. Hoffmann-La Roche Ltd
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Applied Biological Materials (abm), Inc
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Abcam plc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Cell Signaling Technology, Inc.
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.8.5. Meridian Bioscience Inc.
9.5.8.6. Company Overview
9.5.8.7. Product Portfolio
9.5.8.8. Financial Overview
9.5.8.9. Business Strategies and Development
9.5.9. Sartorius CellGenix GmbH
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Bio-Techne
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. Proteintech Group, Inc
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. Miltenyi Biotec
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. Creative Bioarray
9.5.13.1. Company Overview
9.5.13.2. Product Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development
9.5.14. Akron Biotech
9.5.14.1. Company Overview
9.5.14.2. Product Portfolio
9.5.14.3. Financial Overview
9.5.14.4. Business Strategies and Development
9.5.15. Sino Biological Inc.
9.5.15.1. Company Overview
9.5.15.2. Product Portfolio
9.5.15.3. Financial Overview
9.5.15.4. Business Strategies and Development
9.5.16. Repligen corporation
9.5.16.1. Company Overview
9.5.16.2. Product Portfolio
9.5.16.3. Financial Overview
9.5.16.4. Business Strategies and Development
9.5.17. LEADGENE BIOMEDICAL, INC.
9.5.17.1. Company Overview
9.5.17.2. Product Portfolio
9.5.17.3. Financial Overview
9.5.17.4. Business Strategies and Development
9.5.18. PeproTech In
9.5.18.1. Company Overview
9.5.18.2. Product Portfolio
9.5.18.3. Financial Overview
9.5.18.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations
관련자료
